Chief Editor Enrique Chacon-Cruz, M.D., MSc.

Mexican-born medical doctor with a degree from Guadalajara, Mexico, and further specializations in Pediatrics and Infectious Diseases from institutions in Mexico City and the USA (Eastern Virginia Medical School). He also holds a Master’s degree in Vaccinology and Drug Development from the University of Siena, Italy.

Currently, he is the CEO and Founder of “Think Vaccines” (Research, Education, and Consultancy for Vaccines and Vaccinology) based in Houston, Texas.

With over 140 research items published and/or presented at international meetings and more than 500 international lectures, all focused on vaccines, vaccination, clinical trials, and vaccine-preventable diseases. The latter conducted independently or in association with the Centers for Disease Control and Prevention (CDC), the University of California in San Diego, Eastern Virginia Medical School, and several other institutions.

Additionally, He is the President of the Immunization Committee of the Mexican Association of Pediatric Infectious Diseases, he is a member of the Mexican Committee for the Elimination of Measles, Rubella, and Congenital Rubella, member of the Immunization and of the Health Equity Committees of the European Society of Medicine and Overseas Fellow, Royal Society of Medicine, United Kingdom. He is also the former Director of the Mexican Active Surveillance Network for Bacterial Meningitis and the former Head of the Pediatric Infectious Diseases Department and the Research Department at the General Hospital of Tijuana, Baja-California, Mexico.

Chief Editor Felicitas Colombo, MPA. Intelligethics LLC.

Public affairs and policy strategist with over 20 years of experience developing initiatives with regional and global impact while fostering multi-stakeholder collaboration to advance public policy. She holds a Bachelor’s degree in Mass Communications and an Executive Master of Public Administration from the London School of Economics, with a concentration in regulatory analysis, policy design, and risk management.

Throughout her career, Felicitas has advised leading pharmaceutical companies and industry organizations on strategic communications, healthcare policy and market access. Her expertise spans regulatory analysis, government relations, stakeholder engagement, public-private partnerships, advocacy, and health education, with a focus on translating evidence into policy advancements and improving healthcare access. She also brings extensive experience in governance, ethics, transparency, compliance, and risk management at the intersection of public policy and private-sector engagement.

Felicitas is a member of the World Association of PPP Units and Professionals (WAPPP) and the OECD Auditors Alliance. She has also completed executive and specialized training in leadership, ethics, compliance, integrity, and collective action, including the Leadership for the 21st Century: Chaos, Conflict and Courage program at Harvard Kennedy School and the Anti-Corruption Collective Action Certificate at the International Anti-Corruption Academy (IACA).